Theleme Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217M | Buy |
|
|||||
|
2025
Q1 | $205M | Sell |
|
|||||
|
2024
Q4 | $304M | Buy |
|
|||||
|
2024
Q3 | $483M | Hold |
|
|||||
|
2024
Q2 | $858M | Sell |
|
|||||
|
2024
Q1 | $780M | Sell |
|
|||||
|
2023
Q4 | $731M | Buy |
|
|||||
|
2023
Q3 | $712M | Buy |
|
|||||
|
2023
Q2 | $759M | Buy |
|
|||||
|
2023
Q1 | $939M | Buy |
|
|||||
|
2022
Q4 | $1.05B | Sell |
|
|||||
|
2022
Q3 | $710M | Sell |
|
|||||
|
2022
Q2 | $908M | Buy |
|
|||||
|
2022
Q1 | $1.09B | Buy |
|
|||||
|
2021
Q4 | $1.28B | Buy |
|
|||||
|
2021
Q3 | $1.52B | Sell |
|
|||||
|
2021
Q2 | $1.43B | Sell |
|
|||||
|
2021
Q1 | $825M | Buy |
|
|||||
|
2020
Q4 | $558M | Sell |
|
|||||
|
2020
Q3 | $541M | Sell |
|
|||||
|
2020
Q2 | $549M | Sell |
|
|||||
|
2020
Q1 | $267M | Buy |
|
|||||
|
2019
Q4 | $126M | Buy |
|
|||||
|
2019
Q3 | $89.3M | Buy |
|
|||||
|
2019
Q2 | $56.4M | Buy |
|
|||||
|
2019
Q1 | $33.2M | Buy |
|
|||||
|
2018
Q4 | $17.3M | Buy |
|